tetano
Editor, Senior Moderator
Cureus
. 2021 Mar 17;13(3):e13958.
doi: 10.7759/cureus.13958.
Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report
Salma Benyakhlef[SUP] 1 [/SUP], Wahiba Abdellaoui[SUP] 1 [/SUP], Abir Tahri[SUP] 1 [/SUP], Siham Rouf[SUP] 1 [/SUP], Hanane Latrech[SUP] 1 2 [/SUP]
Affiliations
Abstract
During the course of this year, scientific research has revolved around coronavirus disease 2019 (COVID-19), with much uncertainty surrounding its pathogenesis, complications, and mortality as well as limited pediatric evidence. The exact relationship between COVID-19 and new-onset type 1 diabetes, especially in children, remains an unresolved issue. Our case exhibited a unique presentation of diabetic ketoacidosis (DKA) triggering COVID-19 diagnosis at this age. A three-year-old Moroccan boy was admitted with a history of acute dyspnea accompanied by vomiting and weight loss, leading to a diagnosis of DKA. However, evident respiratory distress signs did not disappear, even though glycemic levels were normalized and acidosis resolved. The boy subsequently tested positive for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), with specific biological and radiological findings. Our clinical case potentially augmented the global registry of COVID-19-related diabetes (CoviDiab project) cases and provides a basis for further studies that seek to elucidate the correlation between new-onset type 1 diabetes and SARS-CoV-2 in the pediatric population.
Keywords: covid-19; diabetic ketoacidosis; pediatric t1dm.
. 2021 Mar 17;13(3):e13958.
doi: 10.7759/cureus.13958.
Diabetic Ketoacidosis at Onset of Pediatric Type-1 Diabetes Triggered by Covid-19: An Original Case Report
Salma Benyakhlef[SUP] 1 [/SUP], Wahiba Abdellaoui[SUP] 1 [/SUP], Abir Tahri[SUP] 1 [/SUP], Siham Rouf[SUP] 1 [/SUP], Hanane Latrech[SUP] 1 2 [/SUP]
Affiliations
- PMID: 33880293
- PMCID: PMC8052212
- DOI: 10.7759/cureus.13958
Abstract
During the course of this year, scientific research has revolved around coronavirus disease 2019 (COVID-19), with much uncertainty surrounding its pathogenesis, complications, and mortality as well as limited pediatric evidence. The exact relationship between COVID-19 and new-onset type 1 diabetes, especially in children, remains an unresolved issue. Our case exhibited a unique presentation of diabetic ketoacidosis (DKA) triggering COVID-19 diagnosis at this age. A three-year-old Moroccan boy was admitted with a history of acute dyspnea accompanied by vomiting and weight loss, leading to a diagnosis of DKA. However, evident respiratory distress signs did not disappear, even though glycemic levels were normalized and acidosis resolved. The boy subsequently tested positive for SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), with specific biological and radiological findings. Our clinical case potentially augmented the global registry of COVID-19-related diabetes (CoviDiab project) cases and provides a basis for further studies that seek to elucidate the correlation between new-onset type 1 diabetes and SARS-CoV-2 in the pediatric population.
Keywords: covid-19; diabetic ketoacidosis; pediatric t1dm.